Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke

Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke

BackgroundStroke is a leading cause of long‐term disability worldwide. However, current therapies that promote functional recovery from stroke are limited to physical rehabilitation. No pharmacological therapy is available. Thus, understanding the role of histone deacetylase 2 (HDAC2) in the pathoph...

Full description

Bibliographic Details
Main Authors: Ying Tang, Yu‐Hui Lin, Huan‐Yu Ni, Jian Dong, Hong‐Jin Yuan, Yu Zhang, Hai‐Ying Liang, Meng‐Cheng Yao, Qi‐Gang Zhou, Hai‐Yin Wu, Lei Chang, Chun‐Xia Luo, Dong‐Ya Zhu
Format: Article
Language:English
Published: Wiley 2017-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
epigenetics
functional recovery
histone deacetylase 2
histone deacetylase inhibitor
stroke
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007236

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007236

Similar Items